Lactose (India) Limited (BOM:524202)

India flag India · Delayed Price · Currency is INR
95.10
-4.95 (-4.95%)
At close: Jan 20, 2026
-51.66%
Market Cap1.26B
Revenue (ttm)1.37B
Net Income (ttm)45.18M
Shares Out12.59M
EPS (ttm)3.50
PE Ratio28.51
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6,568
Average Volume6,402
Open100.00
Previous Close100.05
Day's Range95.00 - 100.00
52-Week Range84.27 - 205.00
Beta0.33
RSI44.34
Earnings DateFeb 14, 2026

About Lactose (India)

Lactose (India) Limited engages in the manufacture and trading of pharmaceutical products in India and internationally. The company offers lactose monohydrate; solid dosage forms comprising dry granulated, film, and lacquer coated tablets, as well as uncoated and blister packed solid dose forms; and liquid dosage forms. It also provides disaccharide lactulose, an active pharmaceutical ingredient that is used in the treatment of constipation, hepatitis, encephalopathy, intestinal microflora, dental care, diabetes, and chronic liver disease, as w... [Read more]

Industry Pharmaceutical Preparations
Founded 1991
Employees 140
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524202
Full Company Profile

Financial Performance

In 2024, Lactose (India)'s revenue was 1.16 billion, an increase of 2.20% compared to the previous year's 1.14 billion. Earnings were 51.63 million, a decrease of -23.95%.

Financial Statements